Get started
Glaukos Corporation 2.75% 15-JUN-2027Glaukos Corporation 2.75% 15-JUN-2027Glaukos Corporation 2.75% 15-JUN-2027

Glaukos Corporation 2.75% 15-JUN-2027

No trades
See on Supercharts
Overview
Analysis News

GKOS5209614 chart


Full chart

Key terms


Outstanding amount
‪57.50 M‬USD
Face value
1,000.00USD
Minimum denomination
2,000.00USD
Coupon
2.75% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
−26.77%
Maturity date
Jun 15, 2027
Term to maturity
2 years

About Glaukos Corporation 2.75% 15-JUN-2027


Issuer
Glaukos Corp.
Sector
Health Technology
Industry
Medical Specialties
Home page
glaukos.com
Issue date
Jun 11, 2020
FIGI
BBG00VC8MB10
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.

Analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

News